Patrick Boyle

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. doi request reprint Impact of therapeutic advances on hypoglycaemia in type 2 diabetes
    Patrick J Boyle
    Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA
    Diabetes Metab Res Rev 24:257-85. 2008
  2. ncbi request reprint What are the effects of peroxisome proliferator-activated receptor agonists on adiponectin, tumor necrosis factor-alpha, and other cytokines in insulin resistance?
    Patrick J Boyle
    University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA
    Clin Cardiol 27:IV11-6. 2004
  3. ncbi request reprint Thiazolidinediones and clinical diabetes management: new challenges for the fall of 2007
    Patrick Boyle
    Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87111, USA
    South Med J 100:1063-4. 2007
  4. ncbi request reprint Physiological and behavioral aspects of glycemic control and hypoglycemia in diabetes
    Patrick J Boyle
    Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
    South Med J 100:175-82. 2007
  5. ncbi request reprint Management of diabetes-related hypoglycemia
    Patrick J Boyle
    Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA
    South Med J 100:183-94. 2007
  6. ncbi request reprint Diabetes mellitus and macrovascular disease: mechanisms and mediators
    Patrick J Boyle
    Department of Medicine, University of New Mexico, Albuquerque, New Mexico 87131 0001, USA
    Am J Med 120:S12-7. 2007
  7. ncbi request reprint Application of incretin mimetics and dipeptidyl peptidase IV inhibitors in managing type 2 diabetes mellitus
    Patrick J Boyle
    University of New Mexico, Albuquerque, NM 87131 0001, USA
    J Am Osteopath Assoc 107:S10-6. 2007
  8. ncbi request reprint Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records
    Patrick J Boyle
    Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, USA
    Clin Ther 24:378-96. 2002
  9. pmc Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program
    Allan F Moore
    Center for Human Genetic Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
    Diabetes 57:2503-10. 2008
  10. ncbi request reprint Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit
    Jeffrey M Lubow
    Department of Internal Medicine, University of New Mexico, Albuquerque NM 87131 0001, USA
    Am J Physiol Endocrinol Metab 290:E149-E153. 2006

Research Grants

  1. BRAIN ENERGY METABOLISM AND HYPOGLYCEMIA
    Patrick Boyle; Fiscal Year: 2003

Detail Information

Publications12

  1. doi request reprint Impact of therapeutic advances on hypoglycaemia in type 2 diabetes
    Patrick J Boyle
    Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA
    Diabetes Metab Res Rev 24:257-85. 2008
    ..The extent to which this progress can effect improvement over traditional therapies will, however, depend upon patient (and provider) education, motivation and behaviour change...
  2. ncbi request reprint What are the effects of peroxisome proliferator-activated receptor agonists on adiponectin, tumor necrosis factor-alpha, and other cytokines in insulin resistance?
    Patrick J Boyle
    University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA
    Clin Cardiol 27:IV11-6. 2004
    ....
  3. ncbi request reprint Thiazolidinediones and clinical diabetes management: new challenges for the fall of 2007
    Patrick Boyle
    Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87111, USA
    South Med J 100:1063-4. 2007
  4. ncbi request reprint Physiological and behavioral aspects of glycemic control and hypoglycemia in diabetes
    Patrick J Boyle
    Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
    South Med J 100:175-82. 2007
    ..A companion manuscript reviews the clinical symptoms and fundamentals of hypoglycemia prevention, recognition, and management...
  5. ncbi request reprint Management of diabetes-related hypoglycemia
    Patrick J Boyle
    Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA
    South Med J 100:183-94. 2007
    ....
  6. ncbi request reprint Diabetes mellitus and macrovascular disease: mechanisms and mediators
    Patrick J Boyle
    Department of Medicine, University of New Mexico, Albuquerque, New Mexico 87131 0001, USA
    Am J Med 120:S12-7. 2007
    ..Dual PPAR-alpha/gamma agonists, retinoid receptor agonists, and, to a lesser extent, TZDs, also stimulate cholesterol efflux from macrophages in vitro...
  7. ncbi request reprint Application of incretin mimetics and dipeptidyl peptidase IV inhibitors in managing type 2 diabetes mellitus
    Patrick J Boyle
    University of New Mexico, Albuquerque, NM 87131 0001, USA
    J Am Osteopath Assoc 107:S10-6. 2007
    ..However, the benefits and risks of these agents need to be evaluated more thoroughly, with emphasis on such adverse effects as edema, hypoglycemia, and weight gain...
  8. ncbi request reprint Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records
    Patrick J Boyle
    Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, USA
    Clin Ther 24:378-96. 2002
    ..The results of clinical trials and observational studies have suggested, however, that there are individual differences in the effects of these drugs on blood lipid levels...
  9. pmc Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program
    Allan F Moore
    Center for Human Genetic Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
    Diabetes 57:2503-10. 2008
    ....
  10. ncbi request reprint Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit
    Jeffrey M Lubow
    Department of Internal Medicine, University of New Mexico, Albuquerque NM 87131 0001, USA
    Am J Physiol Endocrinol Metab 290:E149-E153. 2006
    ..min(-1) (P<0.001), and brain alanine uptake trended downward (P<0.08). We conclude that the ATP generated from the physiological increase in BLU during hypoglycemia accounts for no more than 25% of the brain glucose energy deficit...
  11. ncbi request reprint Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes
    Anne L Peters Harmel
    University of Southern California, Keck School of Medicine, Los Angeles, CA, USA
    Curr Med Res Opin 20:215-23. 2004
    ..This study was undertaken to assess the effect of pioglitazone hydrochloride and rosiglitazone maleate on blood lipid levels and glycemic control when these drugs are used as adjunctive therapy in type 2 diabetes...
  12. pmc Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
    Ewan Birney
    Nature 447:799-816. 2007
    ..Together, these studies are defining a path for pursuit of a more comprehensive characterization of human genome function...

Research Grants1

  1. BRAIN ENERGY METABOLISM AND HYPOGLYCEMIA
    Patrick Boyle; Fiscal Year: 2003
    ..Better metabolic control, the key to the prevention of long-term complications of diabetes, will thus become more achievable. ..